1.Effect of Percutaneous Transluminal Coronary Angioplasty in Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction.
Joon Han SHIN ; Seung Jea TAHK ; Han Soo KIM ; Won KIM ; Dong Jin KIM ; Sung Hyon KU ; Yo Han CHO ; So Yeon CHOI ; Byung II CHOI
Korean Circulation Journal 1996;26(6):1091-1098
BACKGROUND: Cardiogenic shock is the most common cause of in-hospital mortality after acute myocardial infarction. Despite improvement in coronary care, the in-hospital mortality rate of cardiogenic shock is very high in conventional conservative therapy. Recently, it was suggested that coronary angioplasty may reduce the mortality associated with cardiogenic shock. METHOD: Thirteen consecutive patients with cardiogenic shock who underwent coronary angioplasty were studied. Shock was not induced by mechanical complications, arrhythmia, hypovolemia and other reversible cause. We collected and analyzed the clinical, hemodynamic survivor groups. RESULTS: Of 13 patients, 11 had successful reperfusion of the infarct-related coronary artery and 2 had unsuccessful reperfusion. Of 11 patients with successful angioplasty, 8 survived at the time of hospital discharge. All patents with unsuccessful angioplasty died in the hospital. Therefore overall hospital survival rate was 62% and the rate increased to 73% in patients with successful reperfusion. Survivor and non-survivor groups in clinical, hemodynamic and angiographic variables were similar except systolic blood pressure and the presence of successful reperfusion. CONCLUSION: In patients with cardiogenic shock, the patency of infarct-related coronary artery was strongly associated with in-hospital mortality. This findings support aggressive interventional strategy in patient with cardiogenic shock complicating acute myocardial infarction.
Angioplasty
;
Angioplasty, Balloon, Coronary*
;
Arrhythmias, Cardiac
;
Blood Pressure
;
Coronary Vessels
;
Hemodynamics
;
Hospital Mortality
;
Humans
;
Hypovolemia
;
Mortality
;
Myocardial Infarction*
;
Reperfusion
;
Shock
;
Shock, Cardiogenic*
;
Survival Rate
;
Survivors
2.Effect of Percutaneous Transluminal Coronary Angioplasty in Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction.
Joon Han SHIN ; Seung Jea TAHK ; Han Soo KIM ; Won KIM ; Dong Jin KIM ; Sung Hyon KU ; Yo Han CHO ; So Yeon CHOI ; Byung II CHOI
Korean Circulation Journal 1996;26(6):1091-1098
BACKGROUND: Cardiogenic shock is the most common cause of in-hospital mortality after acute myocardial infarction. Despite improvement in coronary care, the in-hospital mortality rate of cardiogenic shock is very high in conventional conservative therapy. Recently, it was suggested that coronary angioplasty may reduce the mortality associated with cardiogenic shock. METHOD: Thirteen consecutive patients with cardiogenic shock who underwent coronary angioplasty were studied. Shock was not induced by mechanical complications, arrhythmia, hypovolemia and other reversible cause. We collected and analyzed the clinical, hemodynamic survivor groups. RESULTS: Of 13 patients, 11 had successful reperfusion of the infarct-related coronary artery and 2 had unsuccessful reperfusion. Of 11 patients with successful angioplasty, 8 survived at the time of hospital discharge. All patents with unsuccessful angioplasty died in the hospital. Therefore overall hospital survival rate was 62% and the rate increased to 73% in patients with successful reperfusion. Survivor and non-survivor groups in clinical, hemodynamic and angiographic variables were similar except systolic blood pressure and the presence of successful reperfusion. CONCLUSION: In patients with cardiogenic shock, the patency of infarct-related coronary artery was strongly associated with in-hospital mortality. This findings support aggressive interventional strategy in patient with cardiogenic shock complicating acute myocardial infarction.
Angioplasty
;
Angioplasty, Balloon, Coronary*
;
Arrhythmias, Cardiac
;
Blood Pressure
;
Coronary Vessels
;
Hemodynamics
;
Hospital Mortality
;
Humans
;
Hypovolemia
;
Mortality
;
Myocardial Infarction*
;
Reperfusion
;
Shock
;
Shock, Cardiogenic*
;
Survival Rate
;
Survivors
3.Radiotherapy Result of Brain Stem Tumors.
II Han KIM ; Mi Gyoung YANG ; Charn Il PARK
Journal of the Korean Society for Therapeutic Radiology 1989;7(2):189-196
Twenty five patients with tumors of the brain stem were treated with radiotherapy between 1979 and 1987. Histological diagnosis could be obtained in 6 cases, and other 19 patients were diagnosed by neurologic findings and CT or MRI. Eighteen patients were treated by radical radiotherapy and 6 patients received both operation and radiotherapy, while 1 patient received chemotherapy after radiotherapy. Total dose ranged from 50 Gy to 55 Gy. By an clinical scoring scale at 2 months after radiotherapy, no complete response was obtained, but 16 cases achieved partial response, 2 cases were stable, and 4 cases were deteriorated. The overall survival rate at 3 years was 36%. Age, performance status at diagnosis, degree of cranial nerve involvement, CT pattern of post-contrast enhancement, and clinical response by scoring scale were correlated with survival.
Brain Stem Neoplasms*
;
Brain Stem*
;
Brain*
;
Cranial Nerves
;
Diagnosis
;
Drug Therapy
;
Humans
;
Magnetic Resonance Imaging
;
Neurologic Manifestations
;
Radiotherapy*
;
Survival Rate
4.Morphologic Changes and Ha - ras Mutation in DMBA - treated Rat Mammary Tissues.
Yong Hoon KIM ; Hyun Deuk CHO ; Kwang II KIM ; Joo Han LEE ; Hyun Ho LEE ; Young Sik KIM ; Han Kyeom KIM ; In Sun KIM
Journal of the Korean Cancer Association 1999;31(6):1140-1150
PURPOSE: To understand the morphologic and molecular changes in carcinogen-induced breast tissues, DMBA (10-dimethy1-1,2 benzanthracene) was administrated in Sprague- Dawley female rats. MATERIALS AND METHODS: At 50 days of age, all experimental rats were given 20 mg DMBA by gastric intubation. Until the seventh week after DMBA administration, six rats were sacrificed every week, thereafter all tumors found during 20 weeks were removed every week. The morphologic changes were evaluated in routinely processed sections stained with H-E and with anti-smooth muscle actin antibody. Mutation of Ha-ras codons 12 and 61 was examined by ARMS (amplification refractory mutation system) method in frozen tissues. RESULTS: The epithelial cell proliferation of terminal end buds began 2 weeks after DMBA treatment and progressed to the 6th week, resulting in microscopic malignant tumor in one of the 7th weeks rats. The tumors were developed in 43 of 62 rats (69.4%); 8 benign lesions in 4 rats and 72 malignant tumors in 39 rats. Mutations in the 12th and 61th codon of Ha-ras gene were respectively found in 29.7% and 2.7% of preneoplastic breasts, 25% in benign lesions, 2.6% and 31.6% of malignant tumors. CONCLUSION: DMBA treatment in rats induced epithelial proliferation, then benign and malignant tumors through Ha-ras gene mutation, especially in codon 61 leading to cancer.
9,10-Dimethyl-1,2-benzanthracene*
;
Actins
;
Animals
;
Arm
;
Breast
;
Codon
;
Epithelial Cells
;
Female
;
Genes, ras
;
Humans
;
Intubation
;
Rats*
5.Effect of Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia in Children.
II Han KIM ; Doo Ho CHOI ; Jong Hoon KIM ; Sung Whan HA ; Charn Il PARK ; Hyo Seop AHN
Journal of the Korean Society for Therapeutic Radiology 1989;7(2):269-278
CNS prophylaxis with 18 or 24 Gy cranial irradiation plus intrathecal methotrexate was given to 134 childhood acute lymphoblastic leukemia patients who had got bone marrow remission(M1) after remission induction chemotherapy from August 1979 to December 1986. The rate of initial total CNS relapse was 14.2%(19/134), the rate of isolated CNS relapse was 5.2%(7/134), and the rate of CNS relapse concomittantly combined with bone marrow relapse or testicular relapse was 9%(12/134). Male sex or older age was accociated with higher CNS relapes and the initial peripheral leukocyte count over 50,000/ul had higher relapse rate. Relapse with radiation dose of 18 Gy was somewhat lower than that with 24 Gy. Within 4 years after CNS prophylaxis occurred 89% of the total CNS relapses, 100% of the isolated CNS relapses, and 83% of the combined CNS relapses. Adjusted to exposed cases to risk of CNS relapse, the total CNS relapse rate was 11.9% during maintenance chemotherapy and 4.9% after maintenance chemotherapy.
Bone Marrow
;
Child*
;
Cranial Irradiation*
;
Drug Therapy
;
Humans
;
Leukocyte Count
;
Maintenance Chemotherapy
;
Male
;
Methotrexate
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Recurrence
;
Remission Induction
6.The Management of Intensive therapy Unit .
Yung Suk KIM ; Wan Sik KIM ; Du Ho HAN ; Jnn II MOON ; Dong Ho PARK ; Choo Sik YOON
Korean Journal of Anesthesiology 1973;6(2):259-268
Sine 1961, Dr. Safar postulated the new form of patient, so called "progressive patient care", the hospital service in all countries are fashioned with intensive therapy unit. Particulary the- World Federation Society of Anesthesiologists who have discusincerly at several International congress. we were interested from the literature and visited England, Denmark, United States. and Japan. Of course in Korea, the intensive therapy unit developed from the recovery room and is thus intimately oonnected with anesthesiologists. Here we reviewed with literature and introduced the activities af the intensive therapy unit of Hanyang University Hospital from May 1972 to October 1973, from the point view of the definition, building design, location, capacity, equipment, staff organization and charge of patient, several problems and regulations. Furthermore we recommended with the following new ideas for establishment in hospital of an intensive therapy. unit. a. The design should be arranged on the same floor (OR-RR-Anes.-1TU) and in central part of building. b. Several isolation rooms should be made in 1-T-U. c. One central monitoring system will serve each units. d. The 1-T-U equipment should be used with wall trolly system. e. The regulations of 1-T-U should be noted and advocated by all hospital members. f. The beds in 1-T-U should be arranged with open system.
Denmark
;
England
;
Humans
;
Japan
;
Korea
;
Recovery Room
;
Social Control, Formal
;
United States
7.The Clinical Study of Ro 5-4200 (Flunitrazepam).
Yung Suk KIM ; Chu Sik YOON ; Dong Ho PARK ; Zoon II MOON ; Du Ho HAN ; Wan Sik KIM
Korean Journal of Anesthesiology 1973;6(2):159-164
Benzodiazepine derivatives, chlordiazepoxide(Librium), diazepam(Valium), nitrazepam(Mogadon) and oxazepam(Serenid-D) are mainly used as hypnotics at present. Diazepam has been used mainly for premedication in anesthesia and as an intravenous anesthetic agent. The pharmacological actions of these drugs are tranquilizing effects for central nervous system, slight depression on the cardiovascular and respiratory system, anticonvulsant, anxiolytic and antidepressant effects. A new benzodiazepine derivative, Flunitrazepam(Ro 5-4200) has strong hypnotic action, is anticonvulsant and antidepressant in spite of slight depression of the cardiovascular and respiratory systems. Furthermore the onset and duration of this drug are shorter than the others. In our clinical study, flunitrazepam in the dosage of 0.005mg/kg was administered intravenously, as an intravenous anesthetic induction agent, for 22 surgical adult patients. In each patient, the blood pressure, pulse rate, respiratory rate, minutes volume and arterial gas study were done, before and after administration of the Ro 5-4200. The results are as follows; 1. Dosage of this flunitrazepam is not constant as other benzodiazepines. 2. The effects of flunitrazepam on the cardiovascular system showed slight depression but no effect by one hour post-operation. 3. In respiratory system, the minute volume was depressed slightly and the respiratory rate was increased but negligibly. 4. Undesirable side effects attributed to this drug were not found, except the developing of cough (one case).
Adult
;
Anesthesia
;
Benzodiazepines
;
Blood Pressure
;
Cardiovascular System
;
Central Nervous System
;
Clinical Study*
;
Cough
;
Depression
;
Diazepam
;
Flunitrazepam
;
Heart Rate
;
Humans
;
Hypnotics and Sedatives
;
Premedication
;
Respiratory Rate
;
Respiratory System
;
Tranquilizing Agents
8.Non-Operative Management of 20 Extradural Hematomas.
Soo II KIM ; Hun Joo KIM ; Yang Pya HAN ; Soon Ki HONG ; Chul HU
Journal of Korean Neurosurgical Society 1989;18(6):903-909
The authors presented an analysis non-operative management on 20 epidural hematomas(EDH's) management who had been admitted from June, 1986. to May, 1988. The results were summarized as follows: 1) A number of EDH patients(17/20) with neurologically minor deficits could be successfully managed by conservative management, whereas we underwent surgical evacuation on 3 other cases with clot volume over 50cc. 2) Serial Brain CT scans on 20 patients revealed mostly two types of resolution pattern: One with an intervening expansile phase preceding net resorption(5 cases; 25%), and the other without this phase(15 cases; 75%). 3) All of patients presented mild symptoms and signs(Glasgow Coma Score>13). However, the common complaints were headache and vomiting. 4) The mean period from admission to discharge was 5.6 weeks, and the mean number of followup CT scan was 4.2 times.
Brain
;
Coma
;
Follow-Up Studies
;
Headache
;
Hematoma*
;
Humans
;
Tomography, X-Ray Computed
;
Vomiting
9.A Bilateral Blindness following the General Anesthesia .
Sung Baik KOH ; Tae Suk KIM ; II Hyun RO ; Yung Sam MOON
Korean Journal of Anesthesiology 1980;13(3):300-302
Postoperative total blindness was seen in a 48 year old male who had a laparotomy for traumatic perforation of intestine. General inhalation anesthesia of ether-oxygen-mask with semiclosed system was applied after initial ketamine administration. This unhappy ocular complication could be occur secondary to excessive prolonged external compression to eyeballs with mask or/and prolonged postoperative hypotension.
Anesthesia, General*
;
Anesthesia, Inhalation
;
Blindness*
;
Humans
;
Hypotension
;
Intestines
;
Ketamine
;
Laparotomy
;
Male
;
Masks
10.Extracranial Doses with LIINAC Stereotactic Radiosurgery.
Charn Il PARK ; Wee Saing KANG ; Sung Whan HA ; Young Kap CHO ; II Han KIM
Journal of the Korean Society for Therapeutic Radiology 1996;14(2):159-166
No astract is available
Radiosurgery*